secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardion Health Sciences, Inc. (—)
CIK:        0001642375
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0001493152-23-019500
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardion Health Sciences appoints Jan Hall as CEO; Bret Scholtes resigns effective June 9, 2023
--------------------------------------------------------------------------------

- Bret Scholtes resigns as President, CEO, and director effective June 9, 2023; no disagreement with company.
- Jan Hall appointed President and CEO effective June 19, 2023; former Neutrogena North America President and Coca-Cola SVP.
- Hall's employment: $370,000 base salary, target bonus up to 100% of base, severance up to 12 months.
- Board reduced from five to four directors effective June 10, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642375/000149315223019500/0001493152-23-019500-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642375/000149315223019500/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-019500

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer